StockData
Pasithea Therapeutics Corp. logo

Pasithea Therapeutics Corp. (KTTA) stock

KTTANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$0.51+0.08 (+17.64%)

Close on Nov 18, 2026Market cap $17.07MP/E –Yield –

Pasithea Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Pasithea Therapeutics's total assets was $51.71M at Jun 30, 2026. For fiscal 2025 it was $60.24M, up 275.0% from the year before. The highest annual figure on record is $60.24M in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$60.24M+275.0%
FY2024Dec 31, 2024$16.06M-38.5%
FY2023Dec 31, 2023$26.12M-42.2%
FY2022Dec 31, 2022$45.18M-15.3%
FY2021Dec 31, 2021$53.32M+21403.9%
FY2020Dec 31, 2020$247.96K–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$51.71M+204.0%
Q1 FY2026Mar 31, 2026$56.35M+284.4%
Q4 FY2025Dec 31, 2025$60.24M+275.0%
Q3 FY2025Sep 30, 2025$13.63M-26.9%
Q2 FY2025Jun 30, 2025$17.01M-3.7%
Q1 FY2025Mar 31, 2025$14.66M-34.6%
Q4 FY2024Dec 31, 2024$16.06M-38.5%
Q3 FY2024Sep 30, 2024$18.64M-39.2%
Q2 FY2024Jun 30, 2024$17.66M-53.7%
Q1 FY2024Mar 31, 2024$22.41M-46.7%
Q4 FY2023Dec 31, 2023$26.12M-42.2%
Q3 FY2023Sep 30, 2023$30.66M-38.2%
Q2 FY2023Jun 30, 2023$38.15M-28.1%
Q1 FY2023Mar 31, 2023$42.04M-17.7%
Q4 FY2022Dec 31, 2022$45.18M-15.3%
Q3 FY2022Sep 30, 2022$49.61M+135.8%
Q2 FY2022Jun 30, 2022$53.03M+21285.8%
Q1 FY2022Mar 31, 2022$51.08M–
Q4 FY2021Dec 31, 2021$53.32M–
Q3 FY2021Sep 30, 2021$21.04M–
Q4 FY2020Dec 31, 2020$247.96K–

More Pasithea Therapeutics figures

See a number that looks wrong?